K. Schaff

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer.

H. Kennecke, C. Blanke, W. Cheung, 2013, Current oncology.

A real-world data approach to determine the optimal dosing strategy for pembrolizumab

Tonya Ng, L. Nakashima, K. Schaff, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Adherence with capecitabine: A population-based analysis based on prescription refill data

M. D. de Lemos, L. Kovacic, K. Schaff, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix

H. Kennecke, Y. McConnell, D. Schaeffer, 2018, Annals of Surgical Oncology.

Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis

M. D. de Lemos, K. Schaff, Isabell Kang, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines.

R. Gascoyne, L. Sehn, J. Connors, 2021, Blood advances.

Cancer referral and treatment activity 2010-2015: a population-based study from Vancouver Island.

H. Anderson, C. Holloway, P. Savage, 2016, Current oncology.

R-CHOP with Etoposide Substituted for Doxorubicin (R-CEOP): Excellent Outcome in Diffuse Large B Cell Lymphoma for Patients with a Contraindication to Anthracyclines.

R. Gascoyne, L. Sehn, J. Connors, 2009 .

Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation

M. D. de Lemos, K. Schaff, S. Walisser, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Real-world incidence of venetoclax toxicities in British Columbia

A. Gerrie, M. D. de Lemos, L. Nakashima, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer.

M. D. de Lemos, L. Nakashima, S. Yeung, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.